GNCA Genocea Biosciences, Inc.

-0.04  -1%
Previous Close 5.98
Open 5.97
Price To book 5.15
Market Cap 169.30M
Shares 28,502,000
Volume 86,694
Short Ratio 14.96
Av. Daily Volume 231,389

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Topline data did not meet endpoints - September 2015
Universal vaccine candidate against pneumococcus
Phase 2b data released January 6, 2017. 12-month data due mid-2017. Phase 3 to commence 4Q 2017.
Genital herpes